Development of single domain antibodies targeting protease nexin-1 as a strategy for hemophilia treatment - Vigipallia

0 avis

Development of single domain antibodies targeting protease nexin-1 as a strategy for hemophilia treatment

Archive ouverte

Kawecki, Charlotte | Aymonnier, Karen | Venisse, Laurence | Arocas, Véronique | Christophe, Olivier | Lenting, Peter, J. | Bouton, Marie-Christine | Denis, Cécile

Edité par CCSD -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

La Protéase Nexine-1, un inhibiteur physiologique de la thrombine, cible potentielle dans le traitement de l’hémophilie.

Archive ouverte | Aymonnier, Karen | CCSD

International audience

Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A

Archive ouverte | Aymonnier, Karen | CCSD

International audience

Targeting Protease Nexin-1, a natural anticoagulant to control bleeding in hemophilia A

Archive ouverte | Aymonnier, Karen | CCSD

International audience

Chargement des enrichissements...